HOME >> MEDICINE >> NEWS
Breast cancer survivors experience long-term heart disease risk from radiotherapy

Women who were treated with radiation for breast cancer during the 1980s may be at an increased risk for heart disease compared with the general population, according to a new study in the March 7 Journal of the National Cancer Institute. Despite this increased risk of heart disease, radiation therapy has been previously shown to improve the chances of surviving breast cancer.

Breast cancer patients treated with radiation therapy during the 1970s are thought to have an increased risk of cardiovascular disease, but those treatment procedures are now considered obsolete. However, studies on the association between more modern radiation therapies and cardiovascular disease in breast cancer survivors have been inconclusive.

Maartje Hooning, M.D., of the Netherlands Cancer Institute in Amsterdam, and colleagues compared radiation treatment options, looking for differences in heart disease incidence among 4,414 10-year survivors of breast cancer who were treated between 1970 and 1986. Approximately half of the patients were treated for breast cancer between 1970 and 1980 and half were treated after 1980.

After a median follow-up of 18 years, the researchers identified 942 cases of cardiovascular disease, heart failure being the most common (382 out of 942). The breast cancer patients had an increase in the risk of heart attack, angina (chest pain due to an oxygen shortage in the heart), and congestive heart failure, compared with the general female population. The incidence of angina seemed to increase over time.

The researchers found differences in cardiovascular disease incidence depending on the type of treatment. Overall, patients who received radiation therapy had a greater risk of cardiovascular disease compared with those who received only surgery. In fact, the women who received only surgical treatment had a lower risk of heart attack than the general female population.

To examine the effects of changes i
'"/>

Contact: Liz Savage
elizabeth.savage@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
6-Mar-2007


Page: 1 2 3

Related medicine news :

1. Breast MRI may help determine surgical management of women with newly diagnosed breast cancer
2. Breastfeeding duration rates for infants born in an inner-city WHO/UNICEF Baby-Friendly hospital
3. Breastfeeding and good fats help new moms fight depression
4. Breastfeeding reduces risk of breast cancer for women who delay childbirth
5. Breastfeeding overcomes a genetic tendency toward ear infections, scientists discover
6. Breast cancer treatment procedure gives women more options
7. Breast cancer drug receives FDA approval
8. Breast reconstruction not as safe for obese patients
9. Breast asymmetry surgery improves quality of life, self-esteem
10. Breast discomfort during hormone therapy may indicate increased risk for breast cancer
11. Breast cancer survivors change lifestyle after diagnosis

Post Your Comments:
(Date:1/22/2015)... 23, 2015 VogueQueen is a seasoned and ... and many designers are thrilled to have it lead the ... its new collection of prom dresses for the global market. ... the strategic vision and he focuses on continuing the goal ...
(Date:1/22/2015)... 22, 2015 The federal court overseeing thousands ... District Court, Southern District of West Virginia has upheld a ... proceeding’s first bellwether trial. In an Order dated January 21st, ... after finding that C.R. Bard had not proven a miscarriage ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that ... And for those same twenty-plus years, the team at Doctors ... with the best possible doctor. With the combined breadth ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne ... highest annual revenues in the past three years. Today, the ... dresses. , According to the sales manager of the company, ... them in 2015. This point can be reflected on the ...
(Date:1/22/2015)... As interest in the value of spiritual support ... Rev. Eric J. Hall , president and CEO of ... be the keynote speaker on January 27 at an international ... , The conference, “Hope and Resilience: Innovative and Interdisciplinary Spiritual ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3
(Date:1/23/2015)... Fla. , Jan. 23, 2015  HyGreen, Inc., a ... agreement and partnership with RCA Medical, a subsidiary of ... . Each year, hundreds of millions ... care-associated infections as organisms are transmitted from patient to ...
(Date:1/23/2015)... EAST SETAUKET, N.Y. , Jan. 23, 2015  Lixte Biotechnology ... sites where its Phase I trial of Lixte,s lead compound, ... 5 institutions. John S. Kovach , M.D., ... trial was planned to be completed at a single site. ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: ... CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation ... receipt of $385,642, net of transaction costs, in ... Technology Business Tax Certificate Transfer Program sponsored by ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
Cached News: